Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q4 2025
Institutional positions in Cidara Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CDTX is no longer listed, so this page shows Q4 2025. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 255
- +84 vs. Q3 2025
- Shares held
- 33.3M
- +888.0K (+2.7%) vs. Q3 2025
- Total value
- $7.36B
- +$4.25B (+136.9%) vs. Q3 2025
- New holders
- 139
- 63 more added
- Sold out
- 55
- 46 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 3,365,523 | $743.4M | 7.62% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,007,193 | $443.4M | 0.01% | +776,527+63.1% | Added |
| BlackRock, Inc. | 1,680,662 | $371.2M | 0.01% | +515,209+44.2% | Added |
| HBK Investments L P | 1,260,000 | $278.3M | 3.01% | +1,260,000 | New |
| FIL Ltd | 1,257,574 | $277.8M | 0.21% | +1,257,574 | New |
| UBS Group AG | 1,074,924 | $237.4M | 0.05% | +601,370+127.0% | Added |
| Darwin Global Management, Ltd. | 997,196 | $220.2M | 4.46% | 00.0% | Unchanged |
| Vivo Capital, LLC | 956,670 | $211.3M | 13.66% | −354,755−27.1% | Reduced |
| State Street Corp | 884,374 | $195.3M | 0.01% | +111,615+14.4% | Added |
| Jefferies Financial Group Inc. | 766,520 | $169.3M | 1.39% | +401,520+110.0% | Added |
| Paradigm Biocapital Advisors LP | 759,565 | $167.8M | 4.49% | −201,599−21.0% | Reduced |
| Balyasny Asset Management LLC | 672,890 | $148.6M | 0.28% | +475,330+240.6% | Added |
| Glazer Capital, LLC | 650,191 | $143.6M | 3.78% | +650,191 | New |
| Pentwater Capital Management LP | 565,000 | $124.8M | 0.90% | +565,000 | New |
| Morgan Stanley | 542,722 | $119.9M | 0.01% | +164,538+43.5% | Added |
| Beryl Capital Management LLC | 522,138 | $115.3M | 11.69% | +522,138 | New |
| Geode Capital Management, LLC | 520,591 | $115.0M | 0.01% | +116,477+28.8% | Added |
| Millennium Management LLC | 509,647 | $112.6M | 0.08% | +321,364+170.7% | Added |
| Summit Partners Public Asset Management, LLC | 477,527 | $105.5M | 2.97% | +347,527+267.3% | Added |
| Maverick Capital LtdSuperinvestorMaverick Capital | 455,978 | $100.7M | 1.08% | +38,428+9.2% | Added |
| Farallon Capital Management, L.L.C. | 382,800 | $84.6M | 0.44% | −125,200−24.6% | Reduced |
| Goldman Sachs Group Inc | 377,718 | $83.4M | 0.01% | +107,714+39.9% | Added |
| Qube Research & Technologies Ltd | 358,432 | $79.2M | 0.11% | +322,549+898.9% | Added |
| Citigroup Inc | 348,421 | $77.0M | 0.05% | +346,474+17,795.3% | Added |
| UBS Oconnor LLC | 315,474 | $69.7M | 1.86% | +315,474 | New |
| Logos Global Management LP | 310,000 | $68.5M | 4.56% | −65,000−17.3% | Reduced |
| Squarepoint Ops LLC | 293,586 | $64.9M | 0.13% | +293,586 | New |
| Highland Capital Management Fund Advisors, L.P. | 279,900 | $61.8M | 4.31% | +279,900 | New |
| JPMorgan Chase & Co | 276,551 | $61.1M | 0.00% | +245,880+801.7% | Added |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 275,000 | $60.7M | 0.81% | +275,000 | New |
| FMR LLC | 274,962 | $60.7M | 0.00% | −500,571−64.5% | Reduced |
| Ikarian Capital, LLC | 273,243 | $60.4M | 7.81% | −4,461−1.6% | Reduced |
| Citadel Advisors LLC | 269,389 | $59.5M | 0.04% | −324,604−54.6% | Reduced |
| Adage Capital Partners GP, L.L.C. | 263,332 | $58.2M | 0.09% | −186,668−41.5% | Reduced |
| Point72 Asset Management, L.P. | 250,000 | $55.2M | 0.09% | −1,328,069−84.2% | Reduced |
| Magnetar Financial LLC | 232,537 | $51.4M | 0.50% | +232,537 | New |
| Spruce Street Capital LP | 232,269 | $51.3M | 16.95% | +232,269 | New |
| Weiss Asset Management LP | 224,998 | $49.7M | 0.70% | +224,998 | New |
| Marshall Wace, LLP | 222,763 | $49.2M | 0.05% | −12,547−5.3% | Reduced |
| Polar Asset Management Partners Inc. | 216,998 | $47.9M | 0.95% | +216,998 | New |
| Alliancebernstein L.P. | 212,028 | $46.8M | 0.01% | +194,918+1,139.2% | Added |
| Verition Fund Management LLC | 210,329 | $46.5M | 0.25% | +210,329 | New |
| Alpine Associates Management Inc. | 208,560 | $46.1M | 3.10% | +208,560 | New |
| Bank of America Corp | 207,844 | $45.9M | 0.00% | −33,927−14.0% | Reduced |
| Vivaldi Asset Management, LLC | 205,233 | $45.3M | 2.74% | +205,233 | New |
| Rock Springs Capital Management LP | 204,878 | $45.3M | 2.32% | −44,524−17.9% | Reduced |
| Norges Bank | 200,000 | $44.2M | 0.00% | +200,000 | New |
| Charles Schwab Investment Management Inc | 190,700 | $42.1M | 0.01% | +45,282+31.1% | Added |
| Omni Event Management Ltd | 185,313 | $40.9M | 3.16% | +185,313 | New |
| Neuberger Berman Group LLC | 184,873 | $40.8M | 0.03% | +184,873 | New |
| Sofinnova Investments, Inc. | 180,265 | $39.8M | 1.72% | +126,068+232.6% | Added |
| Northern Trust Corp | 179,081 | $39.6M | 0.01% | +28,913+19.3% | Added |
| Perceptive Advisors LLC | 165,131 | $36.5M | 0.67% | +165,131 | New |
| Fred Alger Management, LLC | 164,575 | $36.4M | 0.14% | −338,302−67.3% | Reduced |
| CNH Partners LLC | 157,709 | $34.8M | 0.73% | +157,709 | New |
| Davidson Kempner Capital Management LP | 155,631 | $34.4M | 0.50% | +155,631 | New |
| Water Island Capital LLC | 150,708 | $33.3M | 4.07% | +150,708 | New |
| Gabelli Funds LLC | 148,666 | $32.8M | 0.22% | +148,666 | New |
| FNY Investment Advisers, LLC | 145,533 | $32.1M | 9.20% | +145,533 | New |
| Oddo BHF Asset Management SAS | 142,500 | $31.5M | 1.18% | +142,500 | New |
| Whitebox Advisors LLC | 125,001 | $27.6M | 0.46% | +125,001 | New |
| Man Group plc | 116,713 | $25.8M | 0.05% | +116,713 | New |
| Highbridge Capital Management LLC | 112,980 | $25.0M | 1.15% | +112,980 | New |
| Renaissance Technologies LLC | 110,560 | $24.4M | 0.04% | +6,300+6.0% | Added |
| Velan Capital Investment Management LP | 108,404 | $23.9M | 13.93% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 100,000 | $22.1M | 2.77% | 00.0% | Unchanged |
| Eversept Partners, LP | 98,721 | $21.8M | 1.22% | +98,721 | New |
| Gabelli & Co Investment Advisers, Inc. | 95,805 | $21.2M | 3.18% | +95,805 | New |
| Walleye Capital LLC | 91,000 | $20.1M | 0.11% | +91,000 | New |
| Acuta Capital Partners, LLC | 89,145 | $19.7M | 13.37% | −52,384−37.0% | Reduced |
| BNP Paribas Arbitrage, SA | 86,869 | $19.2M | 0.01% | +82,410+1,848.2% | Added |
| Superstring Capital Management LP | 85,098 | $18.8M | 10.06% | +16,635+24.3% | Added |
| Sand Grove Capital Management LLP | 80,821 | $17.9M | 6.05% | +80,821 | New |
| Boothbay Fund Management, LLC | 79,587 | $17.6M | 0.46% | −22,277−21.9% | Reduced |
| Barclays PLC | 78,322 | $17.3M | 0.01% | −35,057−30.9% | Reduced |
| Nan Fung Trinity (HK) Ltd | 77,100 | $17.0M | 1.35% | +77,100 | New |
| Slotnik Capital, LLC | 76,245 | $16.8M | 4.61% | +76,245 | New |
| Picton Mahoney Asset Management | 75,000 | $16.6M | 0.18% | +75,000 | New |
| Versor Investments LP | 73,200 | $16.2M | 2.52% | +73,200 | New |
| Artia Global Partners LP | 70,824 | $15.6M | 2.51% | +70,824 | New |
| Ameriprise Financial Inc | 68,986 | $15.2M | 0.00% | +10,500+18.0% | Added |
| Caxton Associates LLP | 68,821 | $15.2M | 0.30% | +68,821 | New |
| Woodline Partners LP | 67,500 | $14.9M | 0.06% | +27,460+68.6% | Added |
| AlphaCore Capital LLC | 66,790 | $14.8M | 0.33% | +66,790 | New |
| Governors Lane LP | 62,325 | $13.8M | 1.27% | +62,325 | New |
| ADAR1 Capital Management, LLC | 59,677 | $13.2M | 0.99% | +38,155+177.3% | Added |
| First Trust Advisors LP | 59,551 | $13.2M | 0.01% | +59,551 | New |
| Public Sector Pension Investment Board | 58,844 | $13.0M | 0.04% | +58,844 | New |
| Bank of New York Mellon Corp | 58,553 | $12.9M | 0.00% | +12,718+27.7% | Added |
| Sagefield Capital LP | 57,075 | $12.6M | 1.07% | +57,075 | New |
| Healthcare of Ontario Pension Plan Trust Fund | 56,375 | $12.5M | 0.02% | +56,375 | New |
| LMR Partners LLP | 56,014 | $12.4M | 0.12% | +56,014 | New |
| Boxer Capital Management, LLC | 53,000 | $11.7M | 2.56% | +5,000+10.4% | Added |
| Harvest Management LLC | 52,500 | $11.6M | 4.29% | +52,500 | New |
| Burkehill Global Management, LP | 50,000 | $11.0M | 0.73% | 00.0% | Unchanged |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 49,495 | $10.9M | 0.26% | +49,495 | New |
| Tudor Investment Corp Et Al | 44,307 | $9.79M | 0.05% | +29,363+196.5% | Added |
| Nuveen, LLC | 43,127 | $9.53M | 0.00% | −2,757−6.0% | Reduced |
| Birnam Oak Advisors, LP | 41,414 | $9.15M | 2.05% | +41,414 | New |
| Athos Capital Ltd | 40,000 | $8.84M | 3.56% | +40,000 | New |